| 000 | 01000 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514190728.0 | ||
| 264 | 0 | _c20040715 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0161-5890 | ||
| 024 | 7 |
_a10.1016/j.molimm.2004.03.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolers, V Michael | |
| 245 | 0 | 0 |
_aThe alternative pathway of complement in disease: opportunities for therapeutic targeting. _h[electronic resource] |
| 260 |
_bMolecular immunology _cJun 2004 |
||
| 300 |
_a147-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xetiology |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 |
_aComplement System Proteins _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aThurman, Joshua M | |
| 773 | 0 |
_tMolecular immunology _gvol. 41 _gno. 2-3 _gp. 147-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molimm.2004.03.012 _zAvailable from publisher's website |
| 999 |
_c14867509 _d14867509 |
||